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Transmyocardial laser revascularization (TMLR) is an
investigational procedure designed to allow perfusion of
ischemic myocardium with oxygenated blood directly from
the left ventricle (LV) through microscopic channels
created with a carbon dioxide laser. TMLR is currently
being offered to patients who are unsuitable candidates
for coronary bypass operations or percutaneous translu-
minal coronary angioplasty and who have severe angina
refractory to medical treatment.
In 1965, Sen and associates1 discovered that the reptil-
ian myocardium is perfused by channels that radiate from
a single ventricle into the surrounding muscle with only a
thin shell of myocardium being supplied by coronary
arteries. Sen’s group attempted to reproduce the reptilian
model of myocardial perfusion by performing transmyo-
cardial acupuncture.
Today, transmyocardial acupuncture has been replaced
by the development of high-energy carbon dioxide lasers
that create transmyocardial channels in beating hearts
without cardiopulmonary bypass (TMLR).
Clinical studies of TMLR have reported decreased
angina, increased treadmill tolerance, and an increase in
relative subendocardial perfusion of laser-treated areas as
measured by nuclear studies and positron emission tomo-
graphic scans 3, 6, and 12 months after the operations.2-4
Recently, a large 1:1 randomized prospective clinical
study comparing TMLR to continued medical manage-
ment in patients with symptomatic, end-stage coronary
artery disease reported improved event-free survival, an-
gina class, and quality of life after TMLR.*
Patients and methods. We performed three autopsies
at the Cleveland Clinic Foundation on patients who had
had TMLR with a high-energy carbon dioxide laser (The
Heart Laser, PLC Medical Systems, Milford, Mass.). Each
patient had had severe angina. Preoperative studies iden-
tified severe diffuse coronary artery atherosclerosis and
LV systolic dysfunction. The patients were not candidates
for conventional revascularization procedures because of
diffuse distal coronary artery atherosclerosis.
The operative procedure used was similar to the pro-
cedure described in previous studies.2, 4, 5 Twenty-five to
thirty channels were created per patient in an area where
ischemic or hibernating myocardium had been discovered
with perioperative thallium or positron emission tomo-
graphic studies (or both). Bypass grafting was not per-
formed in association with TMLR.
The patients died less than 24 hours, 10 days, and 3
weeks after the operation, respectively, allowing the
progression of healing within the laser channels to be
studied.
Causes of death included a perioperative myocardial
infarct in the patient who died suddenly; sepsis, congestive
heart failure, and chronic renal failure in the patient who
died 10 days after the operation; and sepsis, adult respi-
ratory distress syndrome, and multiorgan system failure in
the patient who died 3 weeks after the operation.
In each case, the laser channels were identified at
autopsy as small punctate depressions on the epicardial
surface of the LV. Multiple blocks were taken both
perpendicular and parallel to these depressions. The
blocks were fixed in formalin, embedded in paraffin,
step-sectioned, and stained with hematoxylin-eosin.
Results. In each case, multiple laser channels that
penetrated the entire thickness of the LV from the
epicardium through the endocardium were identified mi-
croscopically. In addition, each case had diffuse fibrosis of
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In the patient who died suddenly, the channels were
bordered by a thin zone of thermal-induced char and were
filled with coagulated protein, blood, and acute inflamma-
tory cells. The inflammation extended into the immedi-
ately adjacent myocardium (Figs. 1 and 2). Collateral
damage was restricted to coagulative necrosis of individ-
ual myocytes adjacent to the laser channels and to a
narrow cuff of subepicardial myocytes surrounding the
beginning of a single channel (Fig. 3). In addition, a recent
subendocardial myocardial infarct of the posterolateral
LV was identified.
In the patient who died 10 days after the operation, the
laser channels continued to have well-demarcated bor-
ders. The zone of thermal-induced char was reduced. The
protein coagulum was replaced by fibroblasts, macro-
phages, multinucleated foreign-body giant cells, and small
blood vessels (Fig. 4). Channels coursing through areas of
myocardial fibrosis showed a delay in progression with
retention of char and protein coagulum. A laser-disrupted
atherosclerotic vessel, as well as calcific emboli in small
intramyocardial vessels, was identified representing a po-
tential complication of TMLR (Fig. 5). Exuberant granu-
lation tissue was present in the epicardium.
In the patient who died 3 weeks after the operation,
well-demarcated transmural channels were identified
filled with granulation tissue and fibrosis (Fig. 6).
Fig. 2. This laser channel from the acute postoperative phase demonstrates a zone of acute inflammation
and necrotic myocytes in the immediately adjacent myocardium. As in Fig. 1, the lumen is filled with
coagulated protein, blood, and acute inflammatory cells.
Fig. 1. This laser channel from the acute postoperative phase demonstrates sharp, well-demarcated
borders surrounded by a thin zone of thermal-induced char and coagulated protein. The lumen of the
channel is filled with coagulated protein, blood, and acute inflammatory cells.
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Several channels contained an intense foreign-body
giant cell response. The giant cells were increased in
number and size as compared with those in the previous
case. Visible material, some polarizable and some
pigmented, was identified in the cytoplasm of several
giant cells. Similar to the previous case, thermal-in-
duced char and protein coagulum persisted in areas of
myocardial fibrosis.
Discussion. In these three autopsies, it was clear that
the laser channels were not patent. Instead, the channels
showed evidence of wound healing with fibrosis. This
finding raises the question of whether this might be a
general finding after TMLR or whether it is peculiar to
those patients who died.
A randomized study has produced evidence that patients
undergoing TMLR have improved symptoms and improved
myocardial perfusion as judged by radionuclide scans when
compared with patients managed medically.* How can this
be reconciled with our findings of lack of perfusion through
the laser channels? One possible explanation is that the
patients undergoing autopsies were different from long-term
*March RJ, Aranki A, Berman DS, Boyce SW, Cohn L, Cooley
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Fig. 3. Collateral damage in the acute postoperative phase included a narrow cuff of necrotic subepicardial
myocytes surrounding the entrance of a single laser channel into the myocardium.
Fig. 4. This laser channel from 10 days after the operation demonstrates sharp, well-demarcated borders.
The lumen of the channel is filled with fibroblasts, macrophages, multinucleated foreign-body giant cells,
and small blood vessels.
The Journal of Thoracic and
Cardiovascular Surgery
Volume 115, Number 6
Brief communications 1 3 8 3
survivors of TMLR and, in fact, died because of channel
occlusion. Another possibility is that the occluded channels
may reopen later, and the third is that the channels remain
occluded but that TMLR stimulates angiogenesis. It has
been observed that the symptom response and improve-
ments in radionuclide scans are not immediate but improved
with time up to 6 months after TMLR.*
It appears that patients do not exhibit consistent im-
provement in myocardial perfusion immediately after
TMLR. Therefore particular care must be taken in the
postoperative management of these incompletely revascu-
larized patients to compensate for the lack of immediate
improvement in myocardial perfusion.
In conclusion, the absence of patent channels in these
three autopsies performed at different postoperative in-
tervals fails to support the hypothesis that laser-induced
transmyocardial channels would carry blood directly from
the LV into the surrounding myocardium. At this point,
the mechanism of the clinical improvement generated by
TMLR remains unknown.
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Fig. 5. Ten days after the operation, this small atherosclerotic intramyocardial coronary artery has been
disrupted by the laser. A dark-colored necrotic laser tract traversing the vessel from top to bottom is
evident.
Fig. 6. The lumen of this well-demarcated laser channel from an autopsy done 3 weeks after the operation
is filled with granulation tissue, fibrosis, and multinucleated foreign-body giant cells.
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